Acumen Pharmaceuticals, Inc. (ABOS) Total Assets by Year
Acumen Pharmaceuticals, Inc. closed fiscal year 2025 with $122.8M in total assets, $52.4M in total liabilities and $70.4M in shareholder equity. This represents a decrease of 48.6% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Acumen Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABOS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $122.8M-48.6% | $239.0M-22.9% | $310.1M+57.8% | $196.6M-14.6% | $230.3M+418.4% | $44.4M |
| Total Liabilities | $52.4M-8.3% | $57.2M+32.5% | $43.2M+452.4% | $7.8M+51.8% | $5.1M-91.8% | $63.0M |
| Total Equity | $70.4M-61.3% | $181.8M-31.9% | $267.0M+41.4% | $188.8M-16.2% | $225.2M+1311.2% | -$18.6M |
ABOS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $116.0M-32.5% | $133.6M-34.6% | $122.8M-48.6% | $142.2M-46.7% | $171.9M-40.5% | $204.5M-32.1% | $239.0M-22.9% | $267.0M-6.8% | $288.9M+62.9% | $301.0M+60.2% | $310.1M+57.8% | $286.4M+40.9% |
| Total Liabilities | $58.7M+7.2% | $46.2M-5.7% | $52.4M-8.3% | $49.0M-1.5% | $54.8M+21.9% | $49.0M+25.7% | $57.2M+32.5% | $49.8M+716.2% | $45.0M+427.1% | $38.9M+343.5% | $43.2M+452.4% | $6.1M-7.8% |
| Total Equity | $57.3M-51.1% | $87.5M-43.8% | $70.4M-61.3% | $93.2M-57.1% | $117.1M-52.0% | $155.5M-40.6% | $181.8M-31.9% | $217.2M-22.5% | $243.9M+44.5% | $262.0M+46.3% | $267.0M+41.4% | $280.3M+42.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Acumen Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Acumen Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Acumen Pharmaceuticals, Inc. closed fiscal year 2025 with $122.8M in total assets, $52.4M in total liabilities and $70.4M in shareholder equity.
How fast is Acumen Pharmaceuticals, Inc.'s total assets growing?
Acumen Pharmaceuticals, Inc. (ABOS) total assets fell by 48.6% year over year, from $239.0M to $122.8M in fiscal year 2025.
How has Acumen Pharmaceuticals, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Acumen Pharmaceuticals, Inc. (ABOS) total assets went from $44.4M in fiscal year 2020 to $122.8M in fiscal year 2025.
What was Acumen Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Acumen Pharmaceuticals, Inc. (ABOS) reported $116.0M in total assets in Q2 2026. This represents a decrease of 32.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Acumen Pharmaceuticals, Inc. (ABOS) reported on that line in every period on record.